A kind of natto product with the effect of regulating intestines and stomach, lowering blood lipid and thrombolytic effect

Abstract

The invention discloses a natto product which has the effect of regulating intestines and stomach, lowering blood fat and dissolving thrombosis. The natto formula is composed of the following components in parts by mass: 15-35 parts of natto powder, 5-8 parts of red yeast rice , 1-5 parts of hawthorn, 3-10 parts of kudzu root extract, 3-10 parts of oligosaccharide; the oligosaccharide is a mixture of fructo-oligosaccharide and isomalto-oligosaccharide. The natto prescription provided by the present invention, the raw materials of the formula are both medicinal and edible materials, which are safe to eat, wide in source, and low in preparation cost. The components are rationally matched according to the formula of the present invention, which has a significant synergistic effect and promotes bowel movement. Doo probiotics proliferate to help digestion, improve gastrointestinal function, and at the same time reduce serum cholesterol and triglyceride levels, dissolve blood vessel thrombus, and comprehensively regulate blood lipids and protect cardiovascular while regulating intestinal microbial flora. The effect is remarkable.

Description

technical field [0001] The invention belongs to the field of health care products, and more specifically relates to a natto product with the functions of regulating stomach, lowering blood fat, and dissolving thrombosis. Background technique [0002] With the improvement of people's living standards, the demand for their own health care is gradually increasing. Among them, the intestinal micro-ecosystem, as a part of the normal intestinal structure, plays a very important role in the normal function of the intestinal tract. However, due to the influence of changes in diet structure, accelerated pace of life, psychological and social factors, and the use of broad-spectrum antibiotics in modern people, there has been a phenomenon of intestinal flora imbalance that makes the host pathogenic, such as acute and chronic diarrhea , constipation, irritable bowel syndrome, inflammatory bowel disease and other digestive system diseases, as well as metabolic-related diseases such as ab...

AI Technical Summary

Problems solved by technology

At the same time, the reduction of intestinal beneficial bacteria will eventually lead to an increase in the synthesis and absorption of cholesterol, aggravating hyperlipidemia

[0003] The treatment of hyperlipidemia is mainly through drug therapy and non-drug therapy. The defect of drug lipid-lowering is that it is easy to produce drug dependence, and long-term use will cause liver and kidney damage, rhabdomyolysis, abdominal pain, rash and other adverse reactions, with large side effects. Very prone to relapse after drug discontinuation

However, there is no report in the field of health care products that use natto as the main component and a composition with reasonable collocation and high activity to regulate the stomach, reduce blood fat, and dissolve thrombosis.

Images